College of Medicine at Princess Nourah bint Abdulrahman University Signs Memorandum of Understanding with Cellenkos, Inc. to Advance Clinical Trials and Cell and Gene Therapies
PNU and Cellenkos sign MOU to advance education and training focused on clinical trials and CAGT HOUSTON, Nov. 9, 2026 /PRNewswire/ -- Cellenkos Inc., a clinical stage biotechnology company, is pleased to share that The College of Medicine at Princess Nourah bint Abdulrahman University...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 82 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.